Scleritis
📧 Sign up to get email alerts when something new happens for Scleritis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-10-23Clinical Trial Update: A Clinical Study to Evaluate the Potential Role of ACTH Gel in Patients With Scleritis [Phase 2]
A Phase 2 clinical study evaluating the potential role of ACTH Gel in patients with scleritis is currently in an unspecified status.
-
CLINICAL_TRIALS trial_result · 2021-02-01Clinical Trial Update: Tofacitinib for Inflammatory Eye Disease [Phase 2]
A Phase 2 trial evaluating tofacitinib for inflammatory eye diseases (uveitis and scleritis) with results posted in 2021; current status is …
-
CLINICAL_TRIALS trial_result · 2018-07-02Clinical Trial Update: Study of H.P. ACTHAR Subcutaneous Gelatin (Gel)(Highly Purified Gel Injection) in Uveitis Patients [Phase 4]
A Phase 4 clinical trial evaluating Acthar Gel for uveitis has completed and posted results in July 2018.
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Infliximab to Treat Non-Infectious Scleritis [Phase 1]
This clinical trial update reports that an early-phase study evaluating infliximab for non-infectious scleritis has completed Phase 1. The t…
-
CLINICAL_TRIALS trial_result · 2015-08-25Clinical Trial Update: Gevokizumab for Active Scleritis [Phase 1, Phase 2]
A Phase 1/2 trial of Gevokizumab for active scleritis has completed, and its results were posted in August 2015.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-06-10Clinical Trial Update: Sirolimus Injections for Autoimmune Scleritis [Phase 1, Phase 2]
A clinical trial evaluating sirolimus injections for autoimmune scleritis has completed phases 1 and 2.
-
CLINICAL_TRIALS trial_result · 2013-08-08Clinical Trial Update: Rituximab in the Treatment of Scleritis and Non-Infectious Orbital Inflammation [Phase 1, Phase 2]
This document summarizes a Phase 1/2 trial of rituximab for scleritis and non-infectious orbital inflammatory disease, which has completed e…
-
CLINICAL_TRIALS trial_result · 2009-09-09Clinical Trial Update: Study Evaluating PSI-697 in Patients With Scleritis [Phase 1]
Phase 1 trial evaluating PSI-697 for scleritis has been terminated. Wyeth, now a subsidiary of Pfizer, sponsored the study.